RSG: West African Gold Miner - Fool's Gold at Peak Prices
Resolute Mining analysis reveals 42% overvaluation at $0.72 vs $0.28 fair value, with execution risks and unsustainable gold margins creating asymmetric downside.
View noteResolute Mining analysis reveals 42% overvaluation at $0.72 vs $0.28 fair value, with execution risks and unsustainable gold margins creating asymmetric downside.
View noteMid-tier gold producer trading at $4.51 vs $2.79 fair value amid peak cycle conditions and complex underground transition. 47% EBITDA margins unsustainable, 35% execution risk.
View noteTrading at $0.105 vs fair value $0.048. Faces AWS/Microsoft competition within 18-24 months. 46% customer concentration, 8.8-month cash runway.
View noteTrading at A$2.81 vs fair value A$1.64, exceptional 68% EBITDA margins face inevitable compression as gold normalises from peak levels.
View noteFair value $3.22 vs current $2.94 (9.5% upside). ROIC 24.8% vs peers 9.5%. IPF integration adds scale, creates synergies.
View noteHOLD rating with A$27.36 fair value vs A$31.64 current price. Australian market leader (40%+ share) facing transformation execution risks and European margin pressure.
View noteACCUMULATE rating with $22.67 fair value vs $1.52 current price. Multi-brand franchise operator executing strategic transformation with 11% revenue CAGR forecast.
View noteReece trades at $14.93 vs fair value $11.80, offering -21% return potential with 68% loss probability amid construction headwinds and competitive pressures.
View noteHOLD rating with $2.17 fair value vs $2.31 current price. Dominant ANZ position, 5.4% yield, but US expansion struggles and margin recovery challenges limit upside.
View noteHOLD rating with $3.82 fair value vs $4.43 current price. Margin compression and execution risks outweigh defensive infrastructure characteristics.
View noteQBE Insurance shows strong transformation with 18.2% ROE and 93.1% combined ratio, but fair value analysis suggests 54% overvaluation at current levels.
View noteDominant Australian airline trading at 38% discount with $19.04 fair value versus $11.89 current price, 20% EBITDA margins, 65% market share.
View note